MHY219 is a potent histone deacetylase (HDAC) inhibitor with an IC50 of 0.276 μM, effectively inhibiting total HDAC enzyme activity. This compound promotes histone H3 and H4 hyperacetylation, leading to cell cycle arrest, apoptosis, and reduced proliferation in cancer cells. Additionally, MHY219 enhances cleavage of PARP, Bax, and cytochrome c levels, while upregulating androgen receptor expression and downregulating Bcl-2 expression. It serves as a valuable research tool for studying prostate cancer mechanisms and potential therapeutic strategies.
MHY219 is a potent histone deacetylase (HDAC) inhibitor with an IC50 of 0.276 μM, effectively inhibiting total HDAC enzyme activity. This compound promotes histone H3 and H4 hyperacetylation, leading to cell cycle arrest, apoptosis, and reduced proliferation in cancer cells. Additionally, MHY219 enhances cleavage of PARP, Bax, and cytochrome c levels, while upregulating androgen receptor expression and downregulating Bcl-2 expression. It serves as a valuable research tool for studying prostate cancer mechanisms and potential therapeutic strategies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
